Omeros (OMER) Return on Sales Growth (3y) (2013 - 2025)

Omeros (OMER) Return on Sales Growth (3y) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 0.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 0.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Omeros 707.67 Mn 707.67 Mn 9.31 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 -1.00
Jun 30, 2022 3.00
Mar 31, 2022 2.00
Dec 31, 2021 -3.00
Sep 30, 2021 38.00
Jun 30, 2021 67.00
Mar 31, 2021 20.00
Dec 31, 2020 -7.00
Sep 30, 2020 4.00
Jun 30, 2020 3.00
Mar 31, 2020 5.00
Dec 31, 2019 -2.00
Sep 30, 2019 3.00
Jun 30, 2019 1.00
Mar 31, 2019 10.00
Dec 31, 2018 2.00
Sep 30, 2018 -22.00
Jun 30, 2018 -34.00
Mar 31, 2018 336.00
Dec 31, 2017 119.00